CONMED CORPORATION Goodwill
CONMED CORPORATION (CNMD) had Goodwill of $796.90 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-07-29
- 2026-06-30: Goodwill $796.90M.
- 2025-12-31: Goodwill $807.01M.
- 2025-09-30: Goodwill $806.92M.
- 2025-06-30: Goodwill $806.93M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $796.90M 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $807.01M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $806.92M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $806.93M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $805.70M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $805.36M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $806.87M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $806.20M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $806.28M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $806.84M 10-K · filed 2026-02-17 | |
| 2023-09-30 | $815.14M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $815.63M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $815.50M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $815.43M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $814.26M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $756.75M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $617.53M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $617.53M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $617.65M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $618.28M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $618.10M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $618.44M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $617.39M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $616.68M 10-Q · filed 2020-07-30 | |
| 2020-03-31 | $615.68M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $618.04M 10-K · filed 2022-02-22 | |
| 2019-09-30 | $615.77M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $616.43M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $615.15M 10-Q · filed 2019-04-26 | |
| 2018-12-31 | $400.44M 10-K · filed 2021-02-22 | |
| 2018-09-30 | $400.98M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $401.10M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $401.86M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $401.95M 10-K · filed 2020-02-24 | |
| 2017-09-30 | $401.79M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $401.13M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $398.15M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $397.66M 10-K · filed 2019-02-25 | |
| 2016-09-30 | $398.38M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $398.15M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $398.39M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $260.65M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $260.75M 10-Q · filed 2015-10-23 | |
| 2015-06-30 | $261.00M 10-Q · filed 2015-07-27 | |
| 2015-03-31 | $255.75M 10-Q · filed 2015-04-24 | |
| 2014-12-31 | $256.23M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $256.22M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $248.43M 10-Q · filed 2014-07-25 | |
| 2014-03-31 | $248.42M 10-Q · filed 2014-04-25 | |
| 2013-12-31 | $248.43M 10-K · filed 2016-02-23 | |
| 2013-09-30 | $248.50M 10-Q · filed 2013-10-28 | |
| 2013-06-30 | $249.16M 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $249.16M 10-Q · filed 2013-04-29 | |
| 2012-12-31 | $248.50M 10-K · filed 2015-02-23 | $256.82M 10-K · filed 2013-02-25 |
| 2012-09-30 | $256.82M 10-Q · filed 2012-10-29 | |
| 2012-06-30 | $234.84M 10-Q · filed 2012-07-30 | |
| 2012-03-31 | $234.79M 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $234.81M 10-K · filed 2014-02-24 | |
| 2011-09-30 | $295.01M 10-Q · filed 2011-11-01 | |
| 2011-06-30 | $294.87M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $295.07M 10-K · filed 2013-02-25 | |
| 2009-12-31 | $290.50M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |